Literature DB >> 26607115

Innovative Medicines Initiative and antibiotic resistance.

Tomislav Kostyanev1, Marc Jm Bonten2, Seamus O'Brien3, Herman Goossens4.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26607115     DOI： 10.1016/S1473-3099(15)00407-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

Review 1.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 2.  Using bacterial genomes and essential genes for the development of new antibiotics.

Authors:  Francisco R Fields; Shaun W Lee; Michael J McConnell
Journal:  Biochem Pharmacol       Date:  2016-12-08       Impact factor: 5.858

Review 3.  Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps.

Authors:  Victoria L Simpkin; Matthew J Renwick; Ruth Kelly; Elias Mossialos
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.